gambogic-acid and Leukemia--Myeloid--Acute

gambogic-acid has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for gambogic-acid and Leukemia--Myeloid--Acute

ArticleYear
Gambogic acid induces growth inhibition and differentiation via upregulation of p21waf1/cip1 expression in acute myeloid leukemia cells.
    Journal of Asian natural products research, 2014, Volume: 16, Issue:10

    Gambogic acid (GA) is the major active ingredient of gamboges, a brownish to orange resin product from Garcinia hanburyi tree in Southeast Asia. This compound exhibits anti-cancer effect on solid tumors. In this study, we investigated the effects of GA on the growth and differentiation of acute myeloid leukemia cells by growth-inhibition detection, morphological changes observation, nitroblue tetrazolium reduction, and the expression of the relative cell-surface differentiation markers. The results showed that GA could inhibit cell growth and promote differentiation in U937 and HL-60 cells. In addition, GA upregulated the expression of p21waf1/cip1 in the two cell lines. Finally, downregulating the p21waf1/cip1 expression with small interfering RNA partially blocked GA-induced cell growth inhibition and differentiation. These results of this study revealed that GA may be used as one of the investigational drugs for acute myeloid leukemia.

    Topics: Antineoplastic Agents, Phytogenic; Asia, Southeastern; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Garcinia; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Molecular Structure; Up-Regulation; Xanthones

2014